Literature DB >> 9710296

The development of a cognitive scale for functional bowel disorders.

B B Toner1, N Stuckless, A Ali, F Downie, S Emmott, D Akman.   

Abstract

OBJECTIVE: The importance of psychosocial factors in patients with Functional Bowel Disorders (FBD) has been well-established. However, most psychosocial measures used in research with FBD patients were not designed or validated on this population. A recent international team report recommended that psychosocial measures be developed to increase our understanding and treatment of FBD. The purpose of this study was to develop a reliable and valid instrument designed specifically to assess cognitions of patients with FBD.
METHOD: An initial set of 204 scale items was generated from a large pool of thought diaries from patients diagnosed with FBD. Items were additionally refined using several methods, including consultation with a multidisciplinary team of international experts on FBD. The remaining 95 items were administered, along with a set of validating questionnaires, to a new sample of 75 FBD patients in Canada and the United States.
RESULTS: The findings indicate that the final 25-item scale has high reliability (Cronbach's alpha = .93; inter-item correlation = .36); high concurrent criterion validity evidenced by the correlation of the scale with a global rating of life interference caused by bowel symptoms (r = .71; p<.001); acceptable convergent validity evidenced by the correlation of the scale with the Dysfunctional Attitudes Scale (r = .38; p<.01); high content validity and face validity; and minimal social desirability contamination (r = .15; NS).
CONCLUSIONS: The Cognitive Scale for Functional Bowel Disorders is a valid and reliable scale that can be used as an outcome measure in evaluating the efficacy of different forms of psychotherapeutic intervention for FBD, and can also serve as a helpful assessment tool for health professionals working with patients diagnosed with FBD.

Entities:  

Mesh:

Year:  1998        PMID: 9710296     DOI: 10.1097/00006842-199807000-00017

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  15 in total

1.  Relationship between cognitive factors and anxiety in individuals with irritable bowel syndrome.

Authors:  Nagisa Sugaya; Shinobu Nomura; Hironori Shimada
Journal:  Int J Behav Med       Date:  2012-09

Review 2.  Psychosocial aspects of the functional gastrointestinal disorders.

Authors:  D A Drossman; F H Creed; K W Olden; J Svedlund; B B Toner; W E Whitehead
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

3.  Symptom Comparisons Between Asian American and White American Women With Irritable Bowel Syndrome.

Authors:  Claire Jungyoun Han; Chaoqun Dong; Monica E Jarrett; Margaret M Heitkemper
Journal:  Gastroenterol Nurs       Date:  2018 May/Jun       Impact factor: 0.978

Review 4.  Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review.

Authors:  F A Luscombe
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

5.  Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern.

Authors:  Margaret Heitkemper; Kevin C Cain; Robert Shulman; Robert Burr; Anne Poppe; Monica Jarrett
Journal:  Dig Dis Sci       Date:  2011-02-03       Impact factor: 3.199

6.  COMT Val158Met Polymorphism and Symptom Improvement Following a Cognitively Focused Intervention for Irritable Bowel Syndrome.

Authors:  Claire J Han; Ruth Kohen; Sangeun Jun; Monica E Jarrett; Kevin C Cain; Robert Burr; Margaret M Heitkemper
Journal:  Nurs Res       Date:  2017 Mar/Apr       Impact factor: 2.381

7.  Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessions.

Authors:  Monica E Jarrett; Kevin C Cain; Robert L Burr; Vicky L Hertig; Sheldon N Rosen; Margaret M Heitkemper
Journal:  Am J Gastroenterol       Date:  2009-08-18       Impact factor: 10.864

8.  TPH gene polymorphisms are associated with disease perception and quality of life in women with irritable bowel syndrome.

Authors:  Sang-Eun Jun; Ruth Kohen; Kevin C Cain; Monica E Jarrett; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2012-11-20       Impact factor: 2.522

9.  A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study).

Authors:  Carla E Flik; Yanda R van Rood; Wijnand Laan; André Jpm Smout; Bas Lam Weusten; Peter J Whorwell; Niek J de Wit
Journal:  BMC Gastroenterol       Date:  2011-12-20       Impact factor: 3.067

10.  Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial.

Authors:  Daniël R Hoekman; Arine M Vlieger; Pieter C Stokkers; Nofel Mahhmod; Svend Rietdijk; Nanne K de Boer; Tim G de Meij; Carla Frankenhuis; Geert R D'Haens; Marc A Benninga
Journal:  J Crohns Colitis       Date:  2021-07-05       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.